You searched for: parvum (Engelska - Maltesiska)

reduction of diarrhoea due to diagnosed cryptosporidium parvum.
tnaqqis ta’ in`idenza ta’ dijareja ikkawżata minn cryptosoridium pavarum.

the compound has a cryptosporidiostatic effect on cryptosporidium parvum.
l- aktar li huwa effettiv huwa fl- istadju liberu tal- parassita (sporozojte, merozojte).

clinical signs of cryptosporidium parvum infection are seen mainly as diarrhoea.
is- sinjal kliniku ewlieni ta’ l-infezzjoni bi cryptosporidium parvum huwa d-dijarea.

prevention of diarrhoea due to diagnosed cryptosporidium parvum, in farms with history of cryptosporidiosis.
prevenzjoni kontra dijareja ikkawżata minn cryptosoridium pavarum,f’irziezet li għandhom storja ta’ kriptosporidjosi.

the active substance in halocur, halofuginone lactate, prevents the growth of cryptosporidium parvum.
is-sustanza attiva f’halocur, halofuginone lactate, ma tħallix lil cryptosporidium parvum jikber.

halocur is used in newborn calves to prevent or reduce diarrhoea due to an organism called cryptosporidium parvum.
halocur jintuża fil-prevenzjoni u t-tnaqqis tad-dijarea kkawżata minn organiżmu magħruf bħala cryptosporidium parvum fl-għoġġiela tat-twelid.

another trial of calves aged from 24 to 48 hours demonstrated that halocur can prevent diarrhoea due to cryptosporidium parvum compared with placebo.
fi studju ieħor ta’ l-għoġġiela ta’ bejn 24 u 48 siegħa intwera li halocur jista’ jipprevjeni d-dijarea kkawżata minn cryptosporidium parvum meta mqabbel mal-plaċebo.

administration should start in the first 24 to 48 hours of age. • reduction of diarrhoea due to diagnosed cryptosporidium parvum.
il- kura g] andha tibda fl- ewwel 24- 48 sieg] a wara t- twelid. • tnaqqis ta ’ in`idenza ta ’ dijareja ikkaw\ ata minn cryptosoridium pavarum.

once the first calf has been treated, all the forthcoming new born calves must be systematically treated as long as the risk for diarrhoea due to c. parvum persists.
jekk g] o[ ol [ie trattat b’ dan il- prodott, kull [] o[ ol li jitwieled wara irid jibqa ’ ji[ i trattat sakemm il - periklu ta ’ dijareja minn c. parvum jippersisti fir- razzett.

halofuginone lactate (ru 38788) is a salt whose antiprotozoal properties and efficacy against cryptosporidium parvum have been demonstrated both in in vitro conditions and in artificial and natural infections.
halofunginone lactate (ru38788) hija kimika li [iet murija li g] andha l- effett li toqtol il- proto\ oi tat- tip cryptosoridium parvum kemm in vitro, kif ukoll f’ infezzjonijiet artifi`jali u naturali. is- sustanza g] andha effett li twaqqaf it- tkabbir tal- kriptosporidja parvum.

the committee for medicinal products for veterinary use (cvmp) concluded that the benefits of halocur outweigh the risks in the prevention and reduction of diarrhoea due to cryptosporidium parvum in newborn calves.
il-kumitat għall-prodotti mediċinali għall-użu veterinarju (cvmp) ikkonkluda li l-benefiċċji ta’ halocur fil-prevenzjoni u t-tnaqqis tad-dijarea kkawżata minn cryptosporidium parvum fl-għoġġiela tat-twelid jegħelbu r-riskji tiegħu.